Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
Identifieur interne : 000828 ( Main/Exploration ); précédent : 000827; suivant : 000829Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
Auteurs : Shibo JiangSource :
- Nature [ 1476-4687 ] ; 2020.
Descripteurs français
- KwdFr :
- Chine, Essais cliniques comme sujet, Humains, Immunité, Infections à coronavirus (), Infections à coronavirus (immunologie), Infections à coronavirus (épidémiologie), Modèles animaux, Pneumopathie virale (), Pneumopathie virale (immunologie), Pneumopathie virale (épidémiologie), Syndrome respiratoire aigu sévère (), Sécurité des patients, Vaccins antiviraux (effets indésirables), Vaccins antiviraux (usage thérapeutique), Virus du SRAS (immunologie), Évaluation préclinique de médicament.
- MESH :
- effets indésirables : Vaccins antiviraux.
- immunologie : Infections à coronavirus, Pneumopathie virale, Virus du SRAS.
- usage thérapeutique : Vaccins antiviraux.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Chine, Essais cliniques comme sujet, Humains, Immunité, Infections à coronavirus, Modèles animaux, Pneumopathie virale, Syndrome respiratoire aigu sévère, Sécurité des patients, Évaluation préclinique de médicament.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Betacoronavirus (drug effects), Betacoronavirus (pathogenicity), China, Clinical Trials as Topic, Coronavirus Infections (epidemiology), Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Drug Evaluation, Preclinical, Humans, Immunity, Models, Animal, Patient Safety, Pneumonia, Viral (epidemiology), Pneumonia, Viral (immunology), Pneumonia, Viral (prevention & control), SARS Virus (immunology), Severe Acute Respiratory Syndrome (prevention & control), Viral Vaccines (adverse effects), Viral Vaccines (therapeutic use).
- MESH :
- chemical , adverse effects : Viral Vaccines.
- chemical , therapeutic use : Viral Vaccines.
- geographic : China.
- drug effects : Betacoronavirus.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- immunology : Coronavirus Infections, Pneumonia, Viral, SARS Virus.
- pathogenicity : Betacoronavirus.
- prevention & control : Coronavirus Infections, Pneumonia, Viral, Severe Acute Respiratory Syndrome.
- Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Immunity, Models, Animal, Patient Safety.
DOI: 10.1038/d41586-020-00751-9
PubMed: 32179860
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000419
- to stream PubMed, to step Curation: 000419
- to stream PubMed, to step Checkpoint: 000769
- to stream Ncbi, to step Merge: 001178
- to stream Ncbi, to step Curation: 001178
- to stream Ncbi, to step Checkpoint: 001178
- to stream Main, to step Merge: 000830
- to stream Main, to step Curation: 000828
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.</title><author><name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32179860</idno><idno type="pmid">32179860</idno><idno type="doi">10.1038/d41586-020-00751-9</idno><idno type="wicri:Area/PubMed/Corpus">000419</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000419</idno><idno type="wicri:Area/PubMed/Curation">000419</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000419</idno><idno type="wicri:Area/PubMed/Checkpoint">000769</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000769</idno><idno type="wicri:Area/Ncbi/Merge">001178</idno><idno type="wicri:Area/Ncbi/Curation">001178</idno><idno type="wicri:Area/Ncbi/Checkpoint">001178</idno><idno type="wicri:Area/Main/Merge">000830</idno><idno type="wicri:Area/Main/Curation">000828</idno><idno type="wicri:Area/Main/Exploration">000828</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.</title><author><name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name></author></analytic><series><title level="j">Nature</title><idno type="eISSN">1476-4687</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (drug effects)</term><term>Betacoronavirus (pathogenicity)</term><term>China</term><term>Clinical Trials as Topic</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (immunology)</term><term>Coronavirus Infections (prevention & control)</term><term>Drug Evaluation, Preclinical</term><term>Humans</term><term>Immunity</term><term>Models, Animal</term><term>Patient Safety</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (immunology)</term><term>Pneumonia, Viral (prevention & control)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Viral Vaccines (adverse effects)</term><term>Viral Vaccines (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Chine</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Immunité</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Modèles animaux</term><term>Pneumopathie virale ()</term><term>Pneumopathie virale (immunologie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Syndrome respiratoire aigu sévère ()</term><term>Sécurité des patients</term><term>Vaccins antiviraux (effets indésirables)</term><term>Vaccins antiviraux (usage thérapeutique)</term><term>Virus du SRAS (immunologie)</term><term>Évaluation préclinique de médicament</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term><term>Drug Evaluation, Preclinical</term><term>Humans</term><term>Immunity</term><term>Models, Animal</term><term>Patient Safety</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chine</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Immunité</term><term>Infections à coronavirus</term><term>Modèles animaux</term><term>Pneumopathie virale</term><term>Syndrome respiratoire aigu sévère</term><term>Sécurité des patients</term><term>Évaluation préclinique de médicament</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list></list><tree><noCountry><name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000828 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000828 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32179860
|texte= Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32179860" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |